Winston Pharmaceuticals, Inc. (WPHM)

Winston Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Mar 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006
Revenue	1.37	1.39	0.45	0.8	0.29
Revenue Growth (YoY)	92.42%	208.17%	-43.43%	171.69%	-
Cost of Revenue	1.84	2.06	3.5	1.85	1.28
Gross Profit	-0.47	-0.67	-3.04	-1.05	-0.99
Selling, General & Admin	1.93	2.06	2.18	1.23	1.15
Operating Expenses	1.94	2.07	2.19	1.24	1.17
Operating Income	-2.41	-2.74	-5.23	-2.29	-2.16
Interest & Investment Income	0	0.01	0.09	0.04	0.08
Other Non Operating Income (Expenses)	0	0	0	0	0.09
EBT Excluding Unusual Items	-2.41	-2.73	-5.14	-2.25	-1.99
Merger & Restructuring Charges	-	-	-	-0.14	-
Legal Settlements	0.08	0.08	-	-	-
Pretax Income	-2.34	-2.66	-5.14	-2.38	-1.99
Earnings From Continuing Operations	-2.34	-2.66	-5.14	-2.38	-1.99
Earnings From Discontinued Operations	-	-	-	-	0.65
Net Income to Company	-2.34	-2.66	-5.14	-2.38	-1.35
Minority Interest in Earnings	-	-	-	-	-0.03
Net Income	-2.34	-2.66	-5.14	-2.38	-1.37
Net Income to Common	-2.34	-2.66	-5.14	-2.38	-1.37
Shares Outstanding (Basic)	67	61	53	54	3
Shares Outstanding (Diluted)	67	61	53	54	3
Shares Change (YoY)	23.57%	14.67%	-1.93%	1644.15%	-
EPS (Basic)	-0.03	-0.04	-0.10	-0.04	-0.44
EPS (Diluted)	-0.03	-0.04	-0.10	-0.04	-0.44
Free Cash Flow	-3.54	-4.2	-3.08	-1.87	-2.04
Free Cash Flow Per Share	-0.05	-0.07	-0.06	-0.03	-0.65
Gross Margin	-34.42%	-47.92%	-	-131.69%	-
Operating Margin	-176.05%	-196.56%	-1156.64%	-286.62%	-731.90%
Profit Margin	-170.44%	-190.40%	-1136.19%	-297.88%	-466.35%
Free Cash Flow Margin	-258.35%	-301.12%	-679.90%	-234.00%	-693.62%
EBITDA	-2.41	-2.73	-5.23	-2.28	-2.14
EBITDA Margin	-175.40%	-195.92%	-	-285.36%	-
D&A For EBITDA	0.01	0.01	0.01	0.01	0.02
EBIT	-2.41	-2.74	-5.23	-2.29	-2.16
EBIT Margin	-176.05%	-196.56%	-	-286.62%	-
Revenue as Reported	1.37	1.39	0.45	0.8	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.